Nine Islands Pharmaceutical (603456.SH) subsidiary intends to participate in investing in Jiaxing Longfeng Entrepreneurship Investment Partnership (limited partnership).

Hexun Finance APP News, Jiuzhou Pharmaceutical (603456.SH) announced that the company's wholly-owned subsidiary, Hongzhou Investment, intends to participate in the investment of Jiaxing Longfeng Entrepreneurial Investment Partnership Enterprise (Limited Partnership). The total subscribed capital of the partnership enterprise is 77 million yuan (including this investment), with Hongzhou Investment as a limited partner subscribing 10 million yuan with its own funds, accounting for 12.987% of the total subscribed capital of the partnership enterprise.